2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth ylpropanoate(CAS: 126544-47-6)
![2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate 2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate](https://cnstatic.chemtradehub.com/structs/126/126544-47-6-bc8f.webp)
CAS号
相关产品
其他供应商提供的 2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth ylpropanoate
基本信息
分子式
C32H44O7
分子量
540.7 g/mol
Physical Properties
熔点
206-213°C
沸点
665°C at 760 mmHg
化学标识符
SMILES
CC(C)C(=O)OCC(=O)[C@]12O[C@@H](O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@@]31C)C6CCCCC6
InChIKey
LUKZNWIVRBCLON-GXOBDPJESA-N
数据库引用
MDL号
MFCD00866004
常见问题
环索奈德是一种化学物质,其英文名称为2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-methylpropanoate,CAS号为126544-47-6。环索奈德是一种1,4-二氢-2H-3,1-benzoxazin-2-one衍生物,主要用于治疗哮喘和过敏性鼻炎等疾病。
环索奈德主要用于治疗哮喘和过敏性鼻炎等疾病。它具有强大的抗炎作用和免疫调节作用,能够有效缓解哮喘症状和减少鼻炎发作。此外,环索奈德还被用于研究以探索其在其他疾病中的潜在应用。
环索奈德在临床应用中被认为是相对安全的,但使用时仍需注意一些安全事项。使用过程中可能会出现一些副作用,如头痛、鼻塞、喉咙痛、声音嘶哑等。对于某些患者,可能会出现更严重的反应,如过敏反应。因此,在使用时应遵循医生的指导,避免接触眼睛、口腔和其他敏感部位,并注意个人防护措施。
环索奈德应储存在阴凉、干燥、通风良好的地方,避免直接暴露在阳光下。储存温度应控制在室温范围内,避免过高或过低的温度,以防药品变质。储存时应使用密封容器,远离火源和热源。此外,储存过程中应避免与其他有毒或易燃物质接触,以确保安全。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序




![[2-[(8S,9R,10S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate](https://cnstatic.chemtradehub.com/structs/779/7793-38-6-5d78.webp)
![4-{[(11beta)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid](https://cnstatic.chemtradehub.com/structs/837/83784-20-7-17eb.webp)
![5-[Bis(4-methylphenyl)methyl]-1H-1,2,4-triazole](https://cnstatic.chemtradehub.com/structs/112/112809-51-5-503e.webp)

![(8S,11R,13S,14S,17S)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-13-methyl-17-(1-propyn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)](https://cnstatic.chemtradehub.com/structs/843/84371-65-3-55b9.webp)
![(11β,16α)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione](https://cnstatic.chemtradehub.com/structs/839/83919-23-7-497e.webp)